한글목차

세계의 바이오폴리머 기반 창상 피복재 시장은 2022년에 3억 4,078만 달러로 평가되며, 2028년까지의 예측 CAGR은 6.41%로, 2028년에는 4억 9,137만 달러에 달할 것으로 예측되며, 예측 기간 중 대폭적인 성장이 전망됩니다.

의료 산업에서 바이오폴리머(천연 또는 합성 고분자) 유래의 상처 드레싱 재료의 개발 및 활용에 중점을 두고 있는 성장 분야입니다. 이러한 상처 드레싱 재료는 생체 적합성, 치유 촉진 기능, 환경 친화적 특성으로 인해 큰 관심을 받고 있습니다.

고급 상처 관리 솔루션에 대한 수요가 증가함에 따라 이 시장은 만성 상처, 외과적 절개, 화상, 외상 등 다양한 유형의 상처에 대응할 수 있도록 설계된 혁신적인 제품을 제공합니다. 이러한 성장의 배경에는 만성질환의 확산, 세계 인구의 고령화, 보다 효과적인 상처 관리의 필요성 등이 있습니다. 바이오폴리머 기반 상처 드레싱은 최적의 치유 환경 유지, 감염 위험 최소화, 환자 편의성 향상과 같은 고유한 이점을 제공합니다.

이 시장에는 제품의 특성을 향상시키기 위한 지속적인 연구개발, 안전성과 유효성을 보장하기 위한 규제에 대한 고려, 시장에서의 입지를 강화하기 위한 전략적 제휴 등이 있습니다. 의료 시스템이 효율적인 상처 치료와 환자 결과를 중시하는 가운데, 바이오폴리머 기반 상처 드레싱 세계 시장은 의료 치료 패러다임의 발전과 상처 치료 요구의 진화에 대응하는 데 있으며, 중요한 역할을 계속하고 있습니다.

시장 촉진요인

1. 만성 창상의 유병률 증가 :

당뇨병성 궤양 및 욕창과 같은 만성 창상의 유병률 증가는 바이오폴리머 기반 상처 드레싱 재료 세계 시장을 촉진하는 중요한 요인입니다. 바이오폴리머 기반 드레싱 재료는 치유 기간이 길고 감염 위험이 높은 이러한 상처를 효과적으로 관리하고 치유를 촉진할 수 있는 맞춤형 솔루션을 제공합니다. 인구 고령화 및 만성질환 증가와 같은 요인으로 인해 만성 창상의 유병률이 증가하고 있으며, 이는 이러한 혁신적인 드레싱 재료에 대한 수요에 기여하고 있습니다.

2. 친환경 및 생체 적합성 소재 :

환경 보호에 대한 인식이 높아지면서 생체 적합성 소재에 대한 요구가 시장 확대의 원동력이 되고 있습니다. 재생한 재료와 생체공학적으로 설계된 폴리머를 원료로 하는 바이오폴리머 기반 드레싱 재료는 생체 적합성을 향상시키면서 지속가능성 목표에 부합합니다.

3. 수술 건수 증가 :

수술 후 상처가 발생하는 수술이 증가함에 따라 바이오폴리머 기반 상처 드레싱 재료에 대한 수요가 증가하고 있습니다. 이러한 드레싱 재료는 수술 상처의 고유한 치유 요구를 충족시키고, 생체 적합성과 최적의 치유 환경을 제공하여 상처 봉합을 가속화하고 합병증을 줄입니다.

주요 시장 과제

1. 제한된 임상적 증거:

바이오폴리머 기반 상처 드레싱의 효능을 지원할 수 있는 확실한 임상 데이터가 없습니다는 점이 도입에 걸림돌이 되고 있습니다. 안전성, 유효성 및 가치를 입증하기 위해서는 강력한 임상적 근거가 필수적이며, 이를 극복하기 위해서는 종합적인 연구와 협력이 필요합니다.

2. 높은 비용 :

바이오폴리머 기반 상처 드레싱은 제조 공정과 고유한 재료 특성으로 인해 기존 드레싱에 비해 비용이 높을 수 있습니다. 이러한 비용 문제는 가격 책정, 구매 용이성 및 상환 결정에 영향을 미칩니다.

3. 다양한 상처 유형 :

다양한 상처 유형에 대응하는 것은 맞춤화, 표준화, 사용 편의성 측면에서 도전이 될 수 있습니다. 결과를 최적화하고 의료진의 채택을 촉진하기 위해서는 이러한 요소들의 적절한 균형을 맞추는 것이 중요합니다.

주요 시장 동향

1. 개별화 상처 관리 솔루션 :

바이오폴리머 기반 드레싱 재료는 개별 상처의 특성에 맞게 치료할 수 있는 범용성을 가지고 있습니다. 이러한 추세는 환자 만족도, 치료 계획 준수 및 치료 결과를 향상시킵니다.

2. 스마트 기술 통합 :

센서와 전자 부품을 통합한 스마트 드레싱 재료는 상처 관리의 혁신적 트렌드입니다. 이러한 드레싱 재료는 실시간 모니터링, 데이터 수집 및 환자 참여를 강화하여 치료 결과를 개선하고 의료 비용을 절감하는 데 기여합니다.

부문별 인사이트

유형별 인사이트

바이오폴리머 기반 상처 드레싱 재료 세계 시장에서 키틴에서 추출한 키토산이 가장 많이 사용되는 바이오폴리머입니다. 키토산 기반 드레싱 재료는 생체 적합성과 항균성을 가지고 있으며, 상처 치료의 요구 사항에 부합합니다.

적응 인사이트 :

바이오폴리머 기반 상처 드레싱은 당뇨병성 궤양 및 정맥성 하지 궤양과 같은 궤양 치료에서 우위를 점하고 있습니다. 습도 조절 특성과 조직 적합성으로 인해 궤양 치료에 효과적입니다.

지역별 인사이트

북미가 바이오폴리머 기반 상처 드레싱 세계 시장을 선도하는 이유는 의료 인프라, 첨단 기술, R&D 및 규제 프레임워크가 잘 갖추어져 있기 때문입니다. 이 지역은 환자 결과와 치료의 질을 중요시하며, 이는 바이오폴리머 기반 드레싱 재료의 성능과 일치합니다.

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 임상시험 분석

제6장 세계의 바이오폴리머 기반 창상 피복재 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율과 예측
  • 유형별(키틴, 키토산, 알긴산나트륨, 알긴산칼슘, 기타)
  • 용도별(화상, 궤양, 절상, 열상, 기타)
  • 최종사용자별(병원, 외래 수술 센터, 기타)
  • 지역별
  • 기업별(2022)
• 제품 맵
  • 유형별
  • 용도별
  • 최종사용자별
  • 지역별

제7장 북미 바이오폴리머 창상 피복재 시장 전망

• 시장 규모·예측
  • 금액별
• 시장 점유율과 예측
  • 유형별
  • 용도별
  • 최종사용자별
  • 국가별
• 북미 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제8장 유럽 : 바이오폴리머 창상 피복재 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율과 예측
  • 유형별
  • 용도별
  • 최종사용자별
  • 국가별
• 유럽 국가별 분석
  • 프랑스
  • 독일
  • 영국
  • 이탈리아
  • 스페인

제9장 아시아태평양의 바이오폴리머 창상 피복재 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율과 예측
  • 유형별
  • 용도별
  • 최종사용자별
  • 국가별
• 아시아태평양 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제10장 남미 바이오폴리머 창상 피복재 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율과 예측
  • 유형별
  • 용도별
  • 최종사용자별
  • 국가별
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제11장 중동 및 아프리카의 바이오폴리머 기반 창상 피복재 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율과 예측
  • 유형별
  • 용도별
  • 최종사용자별
  • 국가별
• MEA : 국가별 분석
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트

제12장 시장 역학

• 촉진요인
  • 만성 창상의 증가.
  • 첨단 기술에 대한 수요의 증가.
• 과제
  • 높은 치료비
  • 인식 부족

제13장 시장 동향과 발전

• 최근 개발
• 합병과 인수
• 제품 출시

제14장 세계의 바이오폴리머 기반 창상 피복재 시장 SWOT 분석

제15장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 힘
• 고객의 힘
• 대체품의 위협

제16장 경쟁 구도

• Business Overview
• Product Offerings
• Recent Developments
• Financials(As Reported)
• Key Personnel
• SWOT Analysis
  • HemCon Medical Technologies, Inc
  • 3M Company
  • Integra LifeSciences Corporation
  • ConvaTec Group PLC
  • Smith & Nephew plc
  • Advancis Medical
  • Coloplast A/S
  • Lohmann & Rauscher GmbH & Co KG
  • Sorbsan
  • KiBou Pharma
  • Johnson & Johnson
  • Marine Polymer Technologies, Inc.
  • Advancis Medical

제17장 전략적 제안

영문목차

The Global Biopolymer-Based Wound Dressing Market, valued at USD 340.78 Million in 2022, is poised for substantial growth in the forecast period, with a projected CAGR of 6.41% through 2028 and expected to reach USD 491.37 Million in 2028. This market represents a thriving segment within the medical industry, focusing on the development and utilization of wound dressings derived from biopolymers-naturally sourced or synthetically produced polymers. These wound dressings have garnered significant interest due to their biocompatibility, healing-promoting capabilities, and environmentally friendly nature.

In response to the growing demand for advanced wound care solutions, the market offers innovative products designed to address a variety of wound types, such as chronic wounds, surgical incisions, burns, and trauma-related injuries. This growth is fueled by factors including the rising prevalence of chronic diseases, an aging global population, and the need for more effective wound management. Biopolymer-based wound dressings offer unique advantages such as maintaining an optimal healing environment, minimizing infection risks, and enhancing patient comfort.

The market is marked by ongoing research and development efforts to enhance product properties, regulatory considerations to ensure safety and efficacy, and strategic collaborations to strengthen market presence. As healthcare systems emphasize efficient wound care and patient outcomes, the Global Biopolymer-Based Wound Dressing Market continues to play a crucial role in advancing medical treatment paradigms and addressing evolving wound care needs.

Key Market Drivers

1. Rising Prevalence of Chronic Wounds:

The increasing prevalence of chronic wounds, such as diabetic ulcers and pressure ulcers, is a significant driver of the Global Biopolymer-Based Wound Dressing Market. Biopolymer-based dressings offer tailored solutions to effectively manage and accelerate the healing of these wounds, which are characterized by prolonged healing times and increased infection risks. The prevalence of chronic wounds has risen due to factors like an aging population and the growing incidence of chronic diseases, contributing to the demand for these innovative dressings.

2. Eco-Friendly and Biocompatible Materials:

Growing environmental sustainability awareness and the need for biocompatible materials are driving the expansion of the market. Biopolymer-based dressings, sourced from renewable materials or bioengineered polymers, align with sustainability goals while offering enhanced biocompatibility.

3. Increasing Number of Surgical Procedures:

The rise in surgical procedures, resulting in post-operative wounds, is driving demand for biopolymer-based wound dressings. These dressings address the unique healing needs of surgical wounds, offering biocompatibility and optimal healing environments to accelerate wound closure and reduce complications.

Key Market Challenges

1. Limited Clinical Evidence:

The lack of robust clinical data supporting the efficacy of biopolymer-based wound dressings is a challenge to their adoption. Strong clinical evidence is crucial for establishing safety, effectiveness, and value, and overcoming this challenge requires comprehensive research and collaboration.

2. High Cost:

The production processes and unique material characteristics of biopolymer-based dressings can lead to higher costs compared to traditional dressings. This cost challenge impacts pricing, affordability, and reimbursement decisions.

3. Varied Wound Types:

Addressing a wide spectrum of wound types poses a challenge in terms of customization, standardization, and ease of use. Striking the right balance between these factors is crucial for optimizing outcomes and facilitating healthcare provider adoption.

Key Market Trends

1. Personalized Wound Care Solutions:

The trend of personalized wound care solutions is gaining momentum, with biopolymer-based dressings offering versatility for tailoring treatments to individual wound characteristics. This trend enhances patient satisfaction, adherence to treatment plans, and healing outcomes.

2. Integration of Smart Technology:

Smart dressings, integrating sensors and electronic components, represent a transformative trend in wound care management. These dressings offer real-time monitoring, data collection, and enhanced patient engagement, contributing to better outcomes and reduced healthcare costs.

Segmental Insights

Type Insights:

Chitosan, derived from chitin, is the dominant type of biopolymer used in the Global Biopolymer-Based Wound Dressing Market. Chitosan-based dressings offer biocompatibility and antimicrobial properties, aligning well with wound care requirements.

Indication Insights:

Biopolymer-based wound dressings find dominance in treating ulcers, including diabetic ulcers and venous leg ulcers. Their moisture-regulating properties and tissue compatibility make them effective for ulcer care.

Regional Insights:

North America leads the Global Biopolymer-Based Wound Dressing Market due to its developed healthcare infrastructure, advanced technologies, research focus, and regulatory framework. The region's emphasis on patient outcomes and quality of care aligns with the capabilities of biopolymer-based dressings.

In summary, the Global Biopolymer-Based Wound Dressing Market is poised for robust growth, driven by various factors such as the rising prevalence of chronic wounds, eco-friendly materials, and the integration of smart technology. However, challenges like limited clinical evidence, cost concerns, and addressing varied wound types need to be addressed to fully capitalize on the market's potential. As the market embraces trends like personalized care and smart technology integration, biopolymer-based wound dressings will play a pivotal role in shaping the future of wound care management.

Key Market Players

• HemCon Medical Technologies, Inc.,
• 3M Company
• Integra LifeSciences Corporation
• ConvaTec Group PLC
• Smith & Nephew plc
• Advancis Medical
• Coloplast A/S
• Lohmann & Rauscher GmbH & Co KG
• Sorbsan
• KiBou Pharma
• Johnson & Johnson
• Marine Polymer Technologies, Inc.
• Advancis Medical

Report Scope:

In this report, the Global Biopolymer Based Wound Dressing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below.

Biopolymer Based Wound Dressing Market, By Type:

• Chitin
• Chitosan
• Sodium Alginate
• Calcium Alginate
• Others

Biopolymer Based Wound Dressing Market, By Applications:

• Burns
• Ulcers
• Cuts and Lacerations
• Others

Biopolymer Based Wound Dressing Market, By End User:

• Hospitals
• Ambulatory Surgery Center
• Others

Biopolymer Based Wound Dressing Market, By region:

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• India
• South Korea
• Australia
• Japan
• Europe
• Germany
• France
• United Kingdom
• Spain
• Italy
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Global Biopolymer Based Wound Dressing Market.

Available Customizations:

• Global Biopolymer Based Wound Dressing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Clinical Trial Analysis

• 5.1. Ongoing Clinical Trials
• 5.2. Completed Clinical Trials
• 5.3. Terminated Clinical Trials
• 5.4. Breakdown of Pipeline, By Development Phase
• 5.5. Breakdown of Pipeline, By Status
• 5.6. Breakdown of Pipeline, By Study Type
• 5.7. Breakdown of Pipeline, By Region
• 5.8. Clinical Trials Heat Map

6. Global Biopolymer Based Wound Dressing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type (Chitin, Chitosan, Sodium Alginate, Calcium Alginate, Others)
  • 6.2.2. By Application (Burns, Ulcers, Cuts and Lacerations, Others)
  • 6.2.3. By End User (Hospitals, Ambulatory Surgery Centers, Others)
  • 6.2.4. By Region
  • 6.2.5. By Company (2022)
• 6.3. Product Map
  • 5.3.1 By Type
  • 5.3.2 By Application
  • 5.3.3 By End User
  • 5.3.4 By Region

7. North America Biopolymer Based Wound Dressing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type (Chitin, Chitosan, Sodium Alginate, Calcium Alginate, Others)
  • 7.2.2. By Application (Burns, Ulcers, Cuts and Lacerations, Others)
  • 7.2.3. By End User (Hospitals, Ambulatory Surgery Centers, Others)
  • 7.2.4. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Biopolymer Based Wound Dressing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. Canada Biopolymer Based Wound Dressing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. Mexico Biopolymer Based Wound Dressing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User

8. Europe Biopolymer Based Wound Dressing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type (Chitin, Chitosan, Sodium Alginate, Calcium Alginate, Others)
  • 8.2.2. By Application (Burns, Ulcers, Cuts and Lacerations, Others)
  • 8.2.3. By End User (Hospitals, Ambulatory Surgery Centers, Others)
  • 8.2.4. By Country
• 8.3. Europe: Country Analysis
  • 8.3.1. France Biopolymer Based Wound Dressing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. Germany Biopolymer Based Wound Dressing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. United Kingdom Biopolymer Based Wound Dressing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecasty
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. Italy Biopolymer Based Wound Dressing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Spain Biopolymer Based Wound Dressing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. Asia-Pacific Biopolymer Based Wound Dressing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type (Chitin, Chitosan, Sodium Alginate, Calcium Alginate, Others)
  • 9.2.2. By Application (Burns, Ulcers, Cuts and Lacerations, Others)
  • 9.2.3. By End User (Hospitals, Ambulatory Surgery Centers, Others)
  • 9.2.4. By Country
• 9.3. Asia-Pacific: Country Analysis
  • 9.3.1. China Biopolymer Based Wound Dressing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. India Biopolymer Based Wound Dressing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Japan Biopolymer Based Wound Dressing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User
  • 9.3.4. South Korea Biopolymer Based Wound Dressing Market Outlook
    • 9.3.4.1. Market Size & Forecast
      • 9.3.4.1.1. By Value
    • 9.3.4.2. Market Share & Forecast
      • 9.3.4.2.1. By Type
      • 9.3.4.2.2. By Application
      • 9.3.4.2.3. By End User
  • 9.3.5. Australia Biopolymer Based Wound Dressing Market Outlook
    • 9.3.5.1. Market Size & Forecast
      • 9.3.5.1.1. By Value
    • 9.3.5.2. Market Share & Forecast
      • 9.3.5.2.1. By Type
      • 9.3.5.2.2. By Application
      • 9.3.5.2.3. By End User

10. South America Biopolymer Based Wound Dressing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type (Chitin, Chitosan, Sodium Alginate, Calcium Alginate, Others)
  • 10.2.2. By Application (Burns, Ulcers, Cuts and Lacerations, Others)
  • 10.2.3. By End User (Hospitals, Ambulatory Surgery Centers, Others)
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Biopolymer Based Wound Dressing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Argentina Biopolymer Based Wound Dressing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. Colombia Biopolymer Based Wound Dressing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Middle East and Africa Biopolymer Based Wound Dressing Market Outlook

• 11.1. Market Size & Forecast
  • 11.1.1. By Value
• 11.2. Market Share & Forecast
  • 11.2.1. By Type (Chitin, Chitosan, Sodium Alginate, Calcium Alginate, Others)
  • 11.2.2. By Application (Burns, Ulcers, Cuts and Lacerations, Others)
  • 11.2.3. By End User (Hospitals, Ambulatory Surgery Centers, Others)
  • 11.2.4. By Country
• 11.3. MEA: Country Analysis
  • 11.3.1. South Africa Biopolymer Based Wound Dressing Market Outlook
    • 11.3.1.1. Market Size & Forecast
      • 11.3.1.1.1. By Value
    • 11.3.1.2. Market Share & Forecast
      • 11.3.1.2.1. By Type
      • 11.3.1.2.2. By Application
      • 11.3.1.2.3. By End User
  • 11.3.2. Saudi Arabia Biopolymer Based Wound Dressing Market Outlook
    • 11.3.2.1. Market Size & Forecast
      • 11.3.2.1.1. By Value
    • 11.3.2.2. Market Share & Forecast
      • 11.3.2.2.1. By Type
      • 11.3.2.2.2. By Application
      • 11.3.2.2.3. By End User
  • 11.3.3. UAE Biopolymer Based Wound Dressing Market Outlook
    • 11.3.3.1. Market Size & Forecast
      • 11.3.3.1.1. By Value
    • 11.3.3.2. Market Share & Forecast
      • 11.3.3.2.1. By Type
      • 11.3.3.2.2. By Application
      • 11.3.3.2.3. By End User

12. Market Dynamics

• 12.1. Drivers
  • 12.1.1 Rise in Incidence of Chronic wound.
  • 12.1.2 Growing Demand for Advance Technologies.
• 12.2. Challenges
  • 12.2.1 High Treatment Cost
  • 12.2.2 Lack of Awareness

13. Market Trends & Developments

• 13.1. Recent Development
• 13.2. Mergers & Acquisitions
• 13.3. Product Launches

14. Global Biopolymer Based Wound Dressing Market: SWOT Analysis

15. Porter's Five Forces Analysis

• 15.1. Competition in the Industry
• 15.2. Potential of New Entrants
• 15.3. Power of Suppliers
• 15.4. Power of Customers
• 15.5. Threat of Substitute Products

16. Competitive Landscape

• 16.1. Business Overview
• 16.2. Product Offerings
• 16.3. Recent Developments
• 16.4. Financials (As Reported)
• 16.5. Key Personnel
• 16.6. SWOT Analysis
  • 16.6.1.1. HemCon Medical Technologies, Inc
  • 16.6.1.2. 3M Company
  • 16.6.1.3. Integra LifeSciences Corporation
  • 16.6.1.4. ConvaTec Group PLC
  • 16.6.1.5. Smith & Nephew plc
  • 16.6.1.6. Advancis Medical
  • 16.6.1.7. Coloplast A/S
  • 16.6.1.8. Lohmann & Rauscher GmbH & Co KG
  • 16.6.1.9. Sorbsan
  • 16.6.1.10. KiBou Pharma
  • 16.6.1.11. Johnson & Johnson
  • 16.6.1.12. Marine Polymer Technologies, Inc.
  • 16.6.1.13. Advancis Medical

17. Strategic Recommendations